Propionic Acidemia Market Outlook:
Propionic Acidemia Market size was valued at USD 1.34 billion in 2025 and is likely to cross USD 2.02 billion by 2035, registering more than 4.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of propionic acidemia is assessed at USD 1.39 billion.
One important factor that will help the market to grow over the forecast period is an increase in prevalence of propionic acidemia. For instance, according to the article published in NCBI Propionic acidemia affects about 1 in 100,000 people in the United States. In some populations, such as Greenland's Inuit population and certain amish communities in Saudi Arabia, the condition seems to be more common. Moreover, propionic acidemia market growth will also be driven by an increasing number of treatment options and a rise in the incidence of ketotic hyperglycaemia and others.
The efficacy and patient compliance of the treatment is enhanced by technological advances in drug delivery systems and formulation. In addition, improved access to healthcare for patients with uncommon diseases such as propionic acidemia is facilitated by the growing use of telemedicine and Digital Health Platforms.
